Cytogenetics in Prenatal Diagnosis: karyotype & CMA Flashcards

1
Q

What options are there aneuploidy testing via CVS and amnio?

A

FISH, karyotype, CMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Can FISH be performed on villi from CVS?

A

Yes

looks at about 400 cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which probes are offered for FISH analysis and can they be ordered seperately?

A
  • probes for chromsomes 13, 18, 21, X & Y
  • they come as a set, you can’t order just one
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How predictive is FISH testing of the final result?

A

95%

screening tool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the advantages of FISH?

A
  • rapid turnaround time (2 days)
  • able to look at multiple cells at one time (if concerned about mosaicism - larger sample size is helpful)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the limitations of FISH?

A
  • the cells evaluated are trophoblasts (if +NIPT is reason for test this could be problematic)
  • still considered screening
  • only looks at 5 chromosomes (unless there is a familial rearrangement not involving one of these chromosomes)
  • probe binds to centromere so if there are issues outside of this region it won’t pick them up (like an imbalance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is an advantage of long term culture of CVS sample?

A

can ‘culture out’ maternal cells that might contaminate the CVS sample

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If mosaicism is found on CVS then what should be offered?

A

Amnio becuase we don’t know if mosaicism is confined to the placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which 2 situations could explain mosaicism of CVS sample?

A
  1. confined placental mosaicism (1-2%) (risk for IUGR)
  2. true fetal mosaicism (highly variable phenotype)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Can amniocentesis be affected by maternal cell contamination?

A

Yes, FISH and chromsoome analysis can still be impacted by maternal cell contamination with a bloody tap. Confined plancental mosaicism can be ruled out though.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

One reason for ordering parental cytogenetic testing is for a history of recurrent pregnancy losses. What is the definition of recurrent pregnancy loss?

A

2 or more clinically recognized pregnancy losses. “Chemical” pregnancies do not count towards this criteria. A chemical pregnancy is a pregnancy only detcted with an at home test.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

One reason that parental cytogenetic testing may be applicable in the prenatal setting is if there is a family history of a chromosome anomaly that could be inherited. What are two examples of these types of chromosome anomalies?

A
  • translocations
  • deletions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

An abnormal NIPT can be a reason to order parental cytogenetic testing. What is something that this test could pick up?

A

maternal mosaicism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

46,XX,der(14;21)+21
explain this karyotype

A

trisomy 21
inherited from a Robertsonian translocation carrier. Their chromosome 14 also has the q arm of 21 on it, leading to a trisomy 21 without an abnormal number of chromosomes
She may called this an unbalanced Robertsonian translcoation but I don’t think that’s correct usage of that term…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For parents of a child with trisomy 21, what is the recurrence risk for future children?

A

1% for any aneuploidy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the risk for having a child with trisomy 21 for a parent who is a carrier of a 14;21 translocation?

risk varies depending on which intended parent has translocation

A

intended mother: 5-15%
intended father: <3%

17
Q

What is the risk of having a child with trisomy 21 for a parent with a 21;22 translcoation?

depends which intended parent has the translocation

A

intended mother: 6%
intended father: 1-2%

18
Q

What is the risk of having a child with trisomy 21 for a carrier of a 21;21 translocation?

A

100%

19
Q

How many chromosomes do Robertsonian carriers have?

A

45

20
Q

46,XY,der(18)t(18;21)(p11.3;q22.3)
Explain this karyotype.

A

Unbalanced karyotype with
partial trisomy of chromosome
21q and partial monosomy of
chromosome 18p

Parent with balanced translocation: 46,XX,t(18;21)(p11.3;q22.3)

21
Q

46,XY,der(18)t(18;21)(p11.3;q22.3)
Explain this karyotype.

A

Unbalanced translocation
resulting in partial trisomy 9 and
partial trisomy 21

balanced parent: 46,XX,t(9;21)(q22;q22.3)

22
Q

46,XX,inv(9)(q2.1q34.3)
Explain this karyotype

A
  • this is balanced
  • paracentric inversion of chromosome 9
  • Resulted in the birth of a child with dicentric recombinant chromosome 9 but these births are RARE
23
Q

What are the risks for live births for babies that inherit paracentric inversions?

A
  • usually these babies do not live to term
  • LOW risk for abnormal live birth (0.1- 0.5%)
  • this is because they form acentric and dicentric fragments in the inversion loop that are not usually viable (none or 2 centromeres during crossing over/recombination)
24
Q

How is a paracentric inversion usually found in an intended parent?

A

history of infertility and/or recurrent miscarriage

25
Q

What factor affects risk related to pericentric inversions?

A
  • the size of the inversion
  • smaller = more likely to lead to live birth
26
Q

How can marker chromosomes be detected?

A

CMA

27
Q

What er percentage of marker chromosomes are familial vs de novo?

A

familail: 20% & generally benign
de novo: 80% associated with abnormal phenotype 13-16% of the time

28
Q

Besdies whoel chromosome aneuploidy and known del/dup syndromes, what finding has the highest risk of resulting in an abnormal live born?

A

marker chromsomes identified in prenatal diagnostic testing

29
Q

When a de novo marker chromosome is identified on prenatal diagnostic testing, what are the risks for an abnormality in the child?

A
  • overall: 13-16% of the time will be assocaited with an abnormal phenotype
  • if the marker chromosome is derived from a non-acrocentric chromosome the risk for abnormal phentoype = 28.6%
  • if the marker chromosome is dervied from an acrocentric chromosome the risk for an abnormal phenotype = 7-11%
  • marker chromosomes that are de novo and derived from non-acrocentric chromosomes have the highest risk for an abnormal phenotype

acrocentric = 13, 14, 15, 21, 22, & Y

30
Q

There are two CMA techniques used in identifying submicroscopic imbalances: comparative genomic hybridization (CGH) and single
nucleotide polymorphisms (SNP). Which one do we use at URMC?

A

Single Nucleotide Polymorphisms (SNP) Analysis uses high-density oligonucleotidebased arrays in which target probes are chosen from DNA locations known to
vary between individuals by a single base pair

31
Q

What is SNP array?

A

DNA (fetal) is labelled and hybridized to the SNP array. Copy number changes are determined by measuring the absolute fluorescence probe intensities of the patient sample compared with the intensities of multiple
normal controls that were independently hybridized (in silico comparison)

32
Q

What are the advantages of the SNP Array for CMA?

A

In addition to detecting copy number variants, uniparental disomy (UPD), mosaicism, zygosity, maternal cell contamination, parent of origin and consanguinity can all be identified. Triploidy, which cannot be detected by aCGH, can be identified by SNP array.

CMA can’t be used to test for UPD, but sometimes it shows up in teh results

33
Q

Which CMA technique can detect triploidy: aCGH or SNP?

A

SNP

34
Q

When is it recommened to order a CMA in the prenatal setting?

A
  • 1+ structural abnormalities on US & undergoing invasive testing. Can replace karyotype
  • structurally normal fetus undergoing invasive diagnostic testing: karyotype or CMA is appropriate (remember that CMA will have lots of benign findings)
  • IUFD or stillbirth (balanced translocations won’t be identified but this doesn’t matter)
35
Q

What is the turnaround time for CMA on direct array vs cultured cells?

direct array = able to use collected sample without amplification (almost never happens with CVS and if amnio is close to 16 weeks)

A
  • direct array: 7-10 days
  • cultured cells: 4 weeks (2 weeks to culture and 2 weeks for analysis)
36
Q

CMA testing of parents to check on a VUS from fetal CMA. Is this testing covered by insurance?

A

NOPE
it’ll be over $1,000 please. for each parent.

37
Q

When should you consider skipping right to an array?

A
  • ultrasound anomalies in the presence of normal NIPT (unlikely to be trisomy 13, 18, or 21)
  • known familial del/dup that is submicroscopic
  • known chromosomal rearrangement previously identified with CMA only (i.e. cryptic rearrangements/very small)
  • US anomalies found close to date of termination being allowed